GW786034 in Treating Patients With Advanced Solid Tumors

NCT00060151 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: pazopanib hydrochloride

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]